Impact of moderate to severe renal impairment on long-term clinical outcomes in patients with atrial fibrillation. Issue 3 (March 2017)

• Record Type: Journal Article
• Authors: Cho, Sung Woo; Hwang, Jin Kyung; Chun, Kwang Jin; Park, Seung-Jung; Park, Kyoung-Min; Kim, June Soo; On, Young Keun
• Is Part Of: Journal of cardiology. Volume 69:Issue 3(2017:Mar.)
• Page Start: 577
• Page End: 583
• Publication Date: 2017-03
• Subjects: Atrial fibrillation -- Renal impairment -- Stroke -- Bleeding; Cardiology -- Periodicals; 616.12
• DOI: 10.1016/j.jjcc.2016.04.006
• Languages: English
• ISSNs: 0914-5087

Abstract

Abstract: Background: The deleterious effect of renal impairment in non-valvular atrial fibrillation (AF) patients has recently been reported. We investigated the impact of moderate to severe renal impairment on long-term clinical outcomes in AF patients. Methods: A total of 2126 AF patients were enrolled and divided into two groups according to ≥ or <60 mL/min estimated glomerular filtration rate (eGFR). Clinical outcomes including all-cause death, cardiac death, ischemic stroke (IS), bleeding, and admission for heart failure (HF) were analyzed. Results: Compared to the ≥60 mL/min eGFR group, <60 mL/min eGFR patients were older; had a higher proportion of females; were more likely to have diabetes, hypertension, and history of stroke; and had higher CHADS2, CHA2 DS2 -VASc, and HAS-BLED scores. During the follow-up period (median 6.23 years), all-cause death, bleeding, admission for HF, and progression to persistent or permanent AF were significantly increased in the <60 mL/min eGFR group compared to the ≥60 mL/min eGFR group. After multivariate Cox regression analyses, <60 mL/min eGFR increased the risk of all-cause death [hazard ratio (HR): 1.84; 95% confidence interval (CI): 1.03–3.28, p = 0.04] and bleeding (HR: 1.28; 95% CI: 1.04–1.57, p = 0.02). IS was only significantly increased in the <60 mL/min eGFR group not receiving antithrombotic treatment. Conclusion: Moderate to severe renal impairment is a poor prognostic factor of long-term clinical outcomes in AF patients.